Dr. Ahmed Kamal, joined Jamia Hamdard (Hamdard University) as the first Pro-Vice Chancellor on October 03, 2017. Dr. Ahmed Kamal was born in Hyderabad, Telangana. He graduated from Osmania University, Hyderabad (India) and obtained his Masters degree in Organic Chemistry. He subsequently completed his Ph.D. in the area of Medicinal Chemistry from the Aligarh Muslim University. On completion of his doctoral degree he joined as a Scientist at the Indian Institute of Chemical Technology (IICT), Hyderabad. He carried out his post-doctoral research work at the University of Portsmouth, England and was a visiting scientist at the University of Alberta, Edmonton, Canada. For the last 30 years, he has pursued his research career at IICT, Hyderabad and also worked in the capacity of Outstanding Scientist at IICT. He was also the Project Director of the National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad. He served as Acting Director of CSIR-IICT during September 2012 till April 2013 and April to June 2015.
His research interests mainly focus on the design and synthesis of gene-targeting compounds as new and novel anti-cancer agents, and their targeted delivery as pro-drugs. New chemical entities for anti-tubercular and anti-malarial activity are also his research avenues. He is also proficient in development of new efficient synthetic methodologies including solid phase, resin bound reagents and chemo-enzymatic strategies that are useful in both basic and applied pharmaceutical chemistry. He has won several honors and awards for his research like CSIR Young Scientist Award in Chemical Sciences (1991), Fellow of the National Academy of Sciences, India (1999), Best Patent Award from the Indian Drug Manufacturers Association (2005), Medal from the Chemical Research Society of India (2005), Ranbaxy Research Award in the field of Pharmaceutical Sciences (2005), UKIERI Standard Award for Biomedical Solutions between India and UK (2006), OPPI Scientist Award from the Organization of Pharmaceutical Producers of India (2009), Fellow of the A. P. Academy of Sciences (2010) and Fellow of Royal Society of Chemistry (2011). He has over 460 publications, more than 8600 citations, 20 review papers and 9 book chapters in the areas of biotransformation and medicinal chemistry. He has filed over 368 patents and five of his US patents have been licensed to a pharmaceutical company for their clinical development at an upfront payment of Rs. 50 lakhs and some compounds from these patents are undergoing pre-clinical studies. He was instrumental in setting up of Biotechnology Incubation centre at S.P. Biotech Park at Hyderabad. About 80 students have completed their Ph.D. work under his guidance and over 10 of them are currently working for their Ph.D. programme in different universities. He is an editorial advisory board member for several prestigious peer–reviewed international journals.
Leave a Reply